Evaluation of carrier added and no carrier added 90Y-EDTMP as bone seeking therapeutic radiopharmaceutical

Pakistan Journal of Pharmaceutical Sciences

Volumn 27, Issue 4, 2014, Pages 813-818

  Khalid, Muhammad ^a   Bokhari, Tanveer Hussain ^b   Ahmad, Mushtaq ^a   Bhatti, Haq Nawaz ^c   Iqbal, Munawar ^c   Ghaffar, Abdul ^b   Qadir, Muhammad Imran ^b  

^a PAKISTAN INSTITUTE OF NUCLEAR SCIENCE AND TECHNOLOGY   (Pakistan)

^b GOVERNMENT COLLEGE UNIVERSITY   (Pakistan)

^c UNIVERSITY OF AGRICULTURE   (Pakistan)

Author keywords

Biodistribution in rats; Carrier added Yttrium 90; EDTMP; No carrier added Yttrium 90; Strontium 90 Yttrium 90 generator

Indexed keywords

DRUG CARRIER; ETHYLENEDIAMINETETRAMETHYLENE PHOSPHONATE Y 90; LIGAND; METAL; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; YTTRIUM 90;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE METASTASIS; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG SCREENING; IN VITRO STUDY; INCUBATION TIME; ISOTOPE LABELING; LABORATORY; NEUTRON RADIATION; NONHUMAN; PH; QUALITY CONTROL; RADIOACTIVITY; RAT;

ANIMALS; BONE NEOPLASMS; DRUG CARRIERS; ISOTOPE LABELING; MALE; ORGANOPHOSPHORUS COMPOUNDS; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; YTTRIUM RADIOISOTOPES;

EID: 84904278989     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. 105Rh-EDTMP and its bone accumulation. Appl. Radiat. Isot., 52: 211-215.
2. 177Lu-EDTMP: A potential therapeutic bone agent. Nucl. Med. Commun., 19: 587-592.
3. 99mTc-Pertechnetate for Diagnostic Radio pharmaceuticals. J. chem. Soc. Pak., 34: 462-467
4. nd edition, Pergamon Press, Oxford, p.187.
5. 177Lu labelled polyaminophosphonates as potential agents for bone pain palliation. Nucl. Med. Commun., 23: 67-74.
6. Chinol M and Hnatowich DJ (1987). Generator-produced yttrium-90 for radio immunotherapy. J. Nucl. Med., 28: 1465-1470.
7. Erdtman G (1976). Neutron activation tables. Verlag Chemie, New York, p.163.
8. 99mTc-Daunorubicin a potential brain imaging and theranostic agent: Synthesis, quality control, characterization, biodistribution and scintigraphy. Nucl. Med. Biol., 40: 148-152.
9. Garnuszek P, Pawlak D, Licinska I and Kaminska A (2003). Evaluation of a freeze-dried kit for EDTMP-based bone-seeking radio pharmaceuticals. Appl. Radiat. Isot., 60: 481-488. (Pubitemid 36369436)
10. Goeckeler WF, Edward B, Volkert WA, Holmes RA, Simon J and Wilson D (1987). Sketal localization of Samarium-153 chelates: Potential Therapeutic Bone agents J. Nucl. Med., 28: 495-504. (Pubitemid 17074172)
11. Goeckeler WF, Troutner DE, Volkert WA, Edward B, Simon J and Wilson D (1985). Sm-153 Radiotherapeutic Bone Agents. Nucl. Med. Biol., 13: 479-482.
12. Hnatowich DJ, Virzi F and Doherty PW (1985). DTPA-coupled antibodies labeled with yttrium-90. J. Nucl. Med., 26: 503-509. (Pubitemid 16192246)
13. Keeling AA, Vaughan ATM and Beaney RP (1989). Yttrium-90-EDTMP: A radiotherapeutic agent in the treatment of leukaemias. Br. J. Cancer., 60: 74-78. (Pubitemid 19187750)
14. 153Sm in rats. Appl. Radiat. Isot., 45: 949-953.
15. Louw WK, Dormehl IC, Rensberg AJ van, Hugo N, Alberts AS, Forsyth OE, Beverley J, Sweetlove MA, Marais J, Lotter MG and Aswegen A van (1996). Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model. Nucl. Med. Biol., 23: 935-940. (Pubitemid 27050679)
16. 99mTc-Sn-EDTMP: freeze-dried kit for bone scanning. Nucl. Med. Biol., 25: 313-317.
17. 188Re-perrhenate in methyl ethyl ketone for concentration purposes. Radiochim. Acta., 95:535-537.
18. 153Sm-EDTMP: Its quality control and bio-distribution. Chung Hua Society, China. Nucl. Sci. J., 34: 196-200.
19. Pecher C (1942). Biological investigations with radioactive calcium and strontium: Preliminary report on the use of radioactive strontium in the treatment of metastatic bone cancer. Univ. Calif. Publ. Pharmacology, 2: 1117-1149.
20. 188Re-ethylenediamine-N,N, N′,N′-tetrakis (methylene phosphonic acid) as a potential agent for bone pain palliation. Nucl. Med. Commun., 23: 75-81.
21. 188Rhenium- EDTMP: A potential therapeutic bone agent. J. Radioanal. Nucl. Chem., 257: 417-420.
22. Reddy EK, Robinson RG and Mansfield CM (1986). Strontium 89 for Palliation of Bone Metastases. J. Natl. Med. Assoc., 78: 27-32. (Pubitemid 16122867)
23. Roesch F, Herzog H, Plag C, Neumaier B, Braun U, Mueller-Gartner HW and Stoecklin G (1996). Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomography. Eur. J. Nucl. Med., 23: 958-966. (Pubitemid 26278797)
24. Serafini AN (2001). Therapy of metastatic bone pain. J. Nucl. Med., 42: 895-906.
25. Volkert WA, Simon J, Ketring AR, Holmes RA, Lattimer LC and Corwin LA (1989). Radiolabeled Phosphonic Acid Chelates: Potential Therapeutic Agents for Treatment of Skeletal Metastases. Drugs Fut., 14: 799-811. (Pubitemid 19231501)